Venom Peptides and Toxins - A Prospective Spearhead in Cancer Treatment

Janet P C Wong1, Bin Li2, Hang F Kwok3

  • 1Faculty of Health Sciences, University of Macau, Avenida da Universidade, Taipa, Macau SAR. China.

Abstract

Insights

Natural peptides and toxins from diverse sources show promise as novel cancer treatments. These compounds exhibit selective toxicity against cancer cells, offering a potential alternative to conventional therapies with fewer side effects.

Area of Science:

  • Biochemistry and Molecular Biology
  • Pharmacology
  • Natural Product Chemistry

Background:

  • Cancer is characterized by uncontrolled cell growth, with resistance to current therapies and significant side effects from treatments like chemotherapy and radiation.
  • Natural products, particularly peptides and toxins from underutilized sources (reptiles, marine life, plants), are emerging as promising anticancer agents.
  • There is a growing need for novel therapeutic strategies to overcome cancer cell resistance and minimize treatment-related toxicity.

Purpose of the Study:

  • To review peptides and toxins from natural sources for their potential in cancer treatment.
  • To highlight their selective mechanisms against malignant cells.
  • To explore their prospective as a novel therapeutic strategy.

Main Methods:

  • Literature review focusing on peptides and toxins from natural sources with anticancer activity.
  • Analysis of structure-activity relationships and pharmacophore modifications.
  • Evaluation of selectivity and cytotoxicity towards cancer versus healthy cells.

Main Results:

  • Peptides and toxins from natural sources demonstrate significant anticancer effects.
  • Structural modifications enhance efficacy and anticancer properties.
  • These compounds exhibit selective targeting of cancer cells with minimal harm to healthy cells.
  • Some peptides display multiple anticancer mechanisms for collective therapeutic impact.

Conclusions:

  • Natural peptides and toxins offer a promising avenue for cancer therapy.
  • Their selectivity and multifaceted mechanisms provide a basis for new therapeutic strategies.
  • Further research into conjugated peptides could lead to novel single-entity treatments.

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
691